サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751266

乳房組織マーカーの市場規模、シェア、動向分析レポート：製品別、材料別、使用タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Breast Tissue Markers Market Size, Share & Trends Analysis Report By Product (Coil, Ribbon), By Material (Bio-absorbable, Non-absorbable), By Usage Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 140 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.50円
乳房組織マーカーの市場規模、シェア、動向分析レポート：製品別、材料別、使用タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月06日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

乳房組織マーカーの市場規模と動向：

乳房組織マーカーの世界市場規模は2024年に7億7,580万米ドルと推計され、2025年から2030年にかけてCAGR 7.0％で成長すると予測されています。

市場成長を促進する主な要因としては、乳がん罹患率の増加、早期発見に関する意識の高まり、低侵襲診断法の採用拡大などが挙げられます。政府の支援策や検診プログラムは、がんに罹患しやすい老年人口の増加とともに、市場成長をさらに促進しています。World Bandのデータによると、2023年には米国の女性総人口の約19%が65歳以上となり、過去数年に比べて大幅に増加しています。

世界の乳がん罹患率の増加や低侵襲手術の採用率の上昇は、市場成長を促進する主な要因の一部です。例えば、米国がん協会によると、乳がんは米国の女性に最も多いがんであり、全がん患者の約30％を占めています。さらに、2025年には新たに約316,950例の浸潤性乳がんが診断され、新たに約59,080例の非浸潤性乳管がん（DCIS）が診断されると推定されています。このような乳がんの高い有病率により、マンモグラフィや画像誘導生検による早期発見への注目度が大幅に高まり、正確な位置特定と追跡ソリューションへの需要が高まっています。

乳房組織マーカーの設計と構成における技術的進歩が市場成長に大きく寄与しています。従来の金属製クリップは、さまざまな画像プラットフォームで視認性を向上させる明確な形状と放射線透過性プロファイルを備えた生体適合性マーカーへと進化しています。開発メーカーは、3D形状マーカー、ポリマー埋め込みマーカー、生体吸収性デザインの開発に投資しており、これらのマーカーは、移動を最小限に抑え、留置後のイメージングにおけるアーチファクトを低減し、MRIやマンモグラフィとの適合性を向上させています。

例えば、2024年3月、マンモトームは、超音波、マンモグラフィ、MRIで視認性を高めるように設計された新しい組織マーカーであるルミマーク生検部位マーカーの510（k）認可を発表しました。放射線科医との共同開発によるこの自己拡張型ニチノールマーカーは、様々な臨床シナリオに対応できるよう、チューリップ、ロータス、ローズの3種類の異なる3D形状があります。510（k）は、乳房組織および腋窩リンパ節のマーキング用として認可されています。そのデザインは、生検部位の特定と経過観察中の患者ケアの精度を向上させることを目的としています。このようなイノベーションにより、ワークフローが改善され、患者の不快感や合併症が軽減されるため、ヘルスケア施設における乳房組織マーカーの需要が増加しています。

さらに、がん予防と早期発見に取り組む政府機関や組織からの取り組みや資金提供の増加も市場成長の原動力となっています。例えば、2025年1月、CDCは、ニューヨーク市の多様な集団に焦点を当て、若年乳がん患者のケアを強化するため、Weill Cornell Medicineに5年間で230万米ドルの基金を提供すると発表しました。ヴェレッド・スターンズ博士とテッサ・シグラー博士が率いるこのイニシアチブは、アクセス、教育、支援サービスを改善し、身体的・文化的ニーズに対応することで、治療のアドヒアランスと生存率を高めることを目的としています。

同様に、National Breast and Cervical Cancer Early Detection Program（NBCCEDP）のような様々なプログラムも、女性の乳がん検診へのアクセスをさらに向上させています。例えば、NBCCEDPは発足以来、1,650万人以上の乳がん・子宮頸がん検診を促進し、8万人近くの浸潤性乳がんを診断してきました。政府の支援、資金提供、公衆衛生キャンペーンが融合することで、予測期間中の市場成長が期待されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 乳房組織マーカー市場の変数、動向、および範囲

  • 市場系統の見通し
    • 補助市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 乳房組織マーカー市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 乳房組織マーカー市場：製品の推定・動向分析

  • セグメントダッシュボード
  • 乳房組織マーカー市場：製品別変動分析と市場シェア、2023年と2030年
  • コイル
  • リボン
  • ウィング
  • U字型
  • 円錐曲線
  • リング
  • ハート
  • ビーナス
  • その他

第5章 乳房組織マーカー市場：材料別の推定・動向分析

  • セグメントダッシュボード
  • 乳房組織マーカー市場：材料別変動分析と市場シェア、2023年と2030年
  • 生体吸収性
  • 非吸収性

第6章 乳房組織マーカー市場：使用タイプ別の推定・動向分析

  • セグメントダッシュボード
  • 乳房組織マーカー市場：使用タイプ別変動分析と市場シェア、2023年と2030年
  • 生検
    • 定位放射線治療
    • 超音波
    • MRI誘導
  • 手術計画
  • その他

第7章 乳房組織マーカー市場：最終用途別の推定・動向分析

  • セグメントダッシュボード
  • 乳房組織マーカー市場：最終用途別変動分析と市場シェア、2023年と2030年
  • 病院
  • 外来手術センター（ASC）
  • 診断センター
  • 専門クリニック

第8章 乳房組織マーカー市場：地域別の推定・動向分析

  • 地域展望
  • 乳房組織マーカー市場：地域別変動分析と市場シェア、2023年と2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 市場参入企業の分類
  • 主要企業プロファイル
    • BD
    • Hologic
    • INRAD, Inc.
    • Carbon Medical Technologies, Inc.
    • Vigeo srl
    • MOLLI Surgical（Stryker）
    • Mammotome
    • Mermaid Medical
  • ヒートマップ分析/企業市況分析
  • 2024年の企業市場シェア予測分析
  • その他の主要市場企業のリスト
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global breast tissue markers market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 6 Global breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 7 Global breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America breast tissue markers market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 11 North America breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 12 North America breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 U.S. breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 14 U.S. breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 15 U.S. breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 16 U.S. breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Canada breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 19 Canada breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 20 Canada breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Mexico breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 22 Mexico breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 23 Mexico breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 24 Mexico breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Europe breast tissue markers market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 28 Europe breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 29 Europe breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 30 UK breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 31 UK breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 32 UK breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 33 UK breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Germany breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 35 Germany breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 36 Germany breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 37 Germany breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 38 France breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 39 France breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 40 France breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 41 France breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Italy breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 43 Italy breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 44 Italy breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 45 Italy breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Spain breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 47 Spain breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 48 Spain breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 49 Spain breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Denmark breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 51 Denmark breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 52 Denmark breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 53 Denmark breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Sweden breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 56 Sweden breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 57 Sweden breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Norway breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 59 Norway breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 60 Norway breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 61 Norway breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific breast tissue markers market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 67 China breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 68 China breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 69 China breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 70 China breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Japan breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 72 Japan breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 73 Japan breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 74 Japan breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 75 India breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 76 India breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 77 India breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 78 India breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Australia breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 80 Australia breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 81 Australia breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 82 Australia breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Thailand breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 84 Thailand breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 85 Thailand breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 86 Thailand breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 87 South Korea breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 88 South Korea breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 89 South Korea breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 90 South Korea breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Latin America breast tissue markers market, by country, 2018 - 2030 (USD Million)
  • Table 92 Latin America breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 93 Latin America breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 94 Latin America breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 95 Latin America breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 96 Brazil breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 97 Brazil breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 98 Brazil breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 99 Brazil breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 100 Argentina breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 101 Argentina breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 102 Argentina breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 103 Argentina breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa breast tissue markers market, by country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 109 South Africa breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 110 South Africa breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 111 South Africa breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 112 South Africa breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 117 UAE breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 118 UAE breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 119 UAE breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 120 UAE breast tissue markers market, by end use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait breast tissue markers market, by product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait breast tissue markers market, by material, 2018 - 2030 (USD Million)
  • Table 123 Kuwait breast tissue markers market, by usage type, 2018 - 2030 (USD Million)
  • Table 124 Kuwait breast tissue markers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Breast Tissue Markers Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 Global Breast Tissue Markers Market, for Coil, 2018 - 2030 (USD Million)
  • Fig. 14 Global Breast Tissue Markers Market, for Ribbon, 2018 - 2030 (USD Million)
  • Fig. 15 Global Breast Tissue Markers Market, for Wing, 2018 - 2030 (USD Million)
  • Fig. 16 Global Breast Tissue Markers Market, for U Shaped, 2018 - 2030 (USD Million)
  • Fig. 17 Global Breast Tissue Markers Market, for Conic, 2018 - 2030 (USD Million)
  • Fig. 18 Global Breast Tissue Markers Market, for Ring, 2018 - 2030 (USD Million)
  • Fig. 19 Global Breast Tissue Markers Market, for Heart, 2018 - 2030 (USD Million)
  • Fig. 20 Global Breast Tissue Markers Market, for Venus, 2018 - 2030 (USD Million)
  • Fig. 21 Global Breast Tissue Markers Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 22 Global Breast Tissue Markers Market, for Bio-absorbable, 2018 - 2030 (USD Million)
  • Fig. 23 Global Breast Tissue Markers Market, for Non-absorbable, 2018 - 2030 (USD Million)
  • Fig. 24 Global Breast Tissue Markers Market, for Biopsy, 2018 - 2030 (USD Million)
  • Fig. 25 Global Breast Tissue Markers Market, for Stereotactic, 2018 - 2030 (USD Million)
  • Fig. 26 Global Breast Tissue Markers Market, for Ultrasound, 2018 - 2030 (USD Million)
  • Fig. 27 Global Breast Tissue Markers Market, for MRI-guided, 2018 - 2030 (USD Million)
  • Fig. 28 Global Breast Tissue Markers Market, for Surgical Planning, 2018 - 2030 (USD Million)
  • Fig. 29 Global Breast Tissue Markers Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global Breast Tissue Markers Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 31 Global Breast Tissue Markers Market, for Ambulatory Surgical Centers (ASC), 2018 - 2030 (USD Million)
  • Fig. 32 Global Breast Tissue Markers Market, for Diagnostic Centers, 2018 - 2030 (USD Million)
  • Fig. 33 Global Breast Tissue Markers Market, for Specialty Clinics, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Outlook, 2024 & 2030
  • Fig. 35 North America Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Breast Tissue Markers Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Breast Tissue Markers Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-567-9

Breast Tissue Markers Market Size & Trends:

The global breast tissue markers market size was estimated at USD 775.8 million in 2024 and is projected to grow at a CAGR of 7.0% from 2025 to 2030. The key factors driving market growth include the increasing incidence of breast cancer, increasing awareness regarding early detection, and growing adoption of minimally invasive diagnostic procedures. Supportive government initiatives and screening programs, along with a growing geriatric population prone to cancer, further propel market growth. According to the World Band data, around 19% of the total female population in the U.S. was aged 65 years and above in 2023, a significant rise over the past years.

The increasing incidence of breast cancer globally and the rising adoption of minimally invasive procedures are some of the major factors driving market growth. For instance, according to the American Cancer Society, breast cancer is the most common type of cancer in women in the U.S., accounting for around 30% of all cancer cases. Moreover, it is estimated that in 2025, around 316,950 new invasive breast cancer cases can be diagnosed, and around 59,080 new cases of ductal carcinoma in situ (DCIS) can be diagnosed, while breast cancer is expected to cause around 42,170 mortalities in the same year. This high prevalence of breast cancer has significantly increased the focus on early detection through mammography and image-guided biopsies, thereby increasing the demand for accurate localization and tracking solutions.

Technological advancements in the design and composition of breast tissue markers have significantly contributed to market growth. Traditional metallic clips have evolved into bio-compatible markers with distinct shapes and radiopacity profiles that improve visibility across various imaging platforms. Manufacturers are investing in developing 3D-shaped markers, polymer-embedded markers, and bio-absorbable designs that minimize migration, reduce artifacts in post-placement imaging, and offer improved compatibility with MRI and mammography.

For instance, in March 2024, Mammotome announced the 510(k) clearance of its LumiMARK Biopsy Site Marker, a novel tissue marker designed for enhanced visibility across ultrasound, mammography, and MRI. Developed in collaboration with radiologists, the self-expanding nitinol markers come in three distinct 3D shapes-Tulip, Lotus, and Rose-to support various clinical scenarios. 510(k) are cleared for marking breast tissue and axillary lymph nodes. Its design aims to improve accuracy in biopsy site localization and patient care during follow-up procedures. These innovations improve the workflow and reduce patient discomfort and complications, increasing the demand for these breast tissue markers in healthcare facilities.

Moreover, the market growth is also driven by increased initiatives and funding from government bodies and organizations dedicated to cancer prevention and early detection. For instance, in January 2025, the CDC announced a five-year, USD 2.3 million fund to Weill Cornell Medicine to enhance care for young breast cancer patients, focusing on diverse populations in New York City. Led by Drs. Vered Stearns and Tessa Cigler, the initiative aims to improve access, education, and support services, addressing physical and cultural needs to boost treatment adherence and survival outcomes.

Similarly, various programs such as the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) further increase women's access to breast cancer screenings. For instance, since its inception, the NBCCEDP has facilitated over 16.5 million breast and cervical cancer screenings, diagnosing nearly 80,000 invasive breast cancers. The convergence of governmental support, funding, and public health campaigns is expected to contribute to market growth over the forecast period.

Global Breast Tissue Markers Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global breast tissue markers market report based on product, material, usage type, end use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Coil
  • Ribbon
  • Wing
  • U Shaped
  • Conic
  • Ring
  • Heart
  • Venus
  • Others
  • Material Outlook (Revenue, USD Million, 2018 - 2030)
  • Bio-absorbable
  • Non-absorbable
  • Usage Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Biopsy
    • Stereotactic
    • Ultrasound
    • MRI-guided
  • Surgical Planning
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Centers
  • Specialty Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased database.
  • 1.5. GVR's internal database
  • 1.6. Secondary sources
  • 1.7. Third Party Perspective
  • 1.8. Primary research
  • 1.9. Details of primary research
  • 1.10. Information or Data Analysis
  • 1.11. Data analysis models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity flow analysis (Model 1)
  • 1.15. Approach 1: Commodity flow approach
  • 1.16. Volume price analysis (Model 2)
  • 1.17. Approach 2: Volume price analysis
  • 1.18. List of Secondary Sources
  • 1.19. List of Primary Sources
  • 1.20. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Tissue Markers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of breast cancer
      • 3.2.1.2. Supportive government initiatives and screening programs
      • 3.2.1.3. Growing geriatric population prone to cancer
      • 3.2.1.4. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of procedures
      • 3.2.2.2. Lack of insurance coverage
  • 3.3. Breast Tissue Markers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Breast Tissue Markers Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Breast Tissue Markers Market: Product Movement Analysis & Market Share, 2023 & 2030
  • 4.3. Coil
    • 4.3.1. Coil Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Ribbon
    • 4.4.1. Ribbon Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Wing
    • 4.5.1. Wing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. U Shaped
    • 4.6.1. U Shaped Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Conic
    • 4.7.1. Conic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Ring
    • 4.8.1. Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Heart
    • 4.9.1. Heart Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Venus
    • 4.10.1. Venus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Breast Tissue Markers Market: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Breast Tissue Markers Market: Material Movement Analysis & Market Share, 2023 & 2030
  • 5.3. Bio-absorbable
    • 5.3.1. Bio-absorbable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Non-absorbable
    • 5.4.1. Non-absorbable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Breast Tissue Markers Market: Usage Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Breast Tissue Markers Market: Usage Type Movement Analysis & Market Share, 2023 & 2030
  • 6.3. Biopsy
    • 6.3.1. Biopsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Stereotactic
      • 6.3.2.1. Stereotactic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Ultrasound
      • 6.3.3.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. MRI-guided
      • 6.3.4.1. MRI-guided Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Surgical Planning
    • 6.4.1. Surgical Planning Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Breast Tissue Markers Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Breast Tissue Markers Market: End Use Movement Analysis & Market Share, 2023 & 2030
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Ambulatory Surgical Centers (ASCs)
    • 7.4.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Diagnostic Centers
    • 7.5.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Specialty Clinics
    • 7.6.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Breast Tissue Markers Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Breast Tissue Markers Market: Regional Movement Analysis & Market Share, 2023 & 2030
  • 8.3. North America
    • 8.3.1. North America Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Scenario
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Mexico Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Denmark Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Sweden Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Japan Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. China Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Argentina Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Reimbursement Scenario
      • 8.7.5.5. Kuwait Breast Tissue Markers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. BD
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Hologic
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. INRAD, Inc.
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Carbon Medical Technologies, Inc.
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Vigeo srl
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. MOLLI Surgical (Stryker)
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Mammotome
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Mermaid Medical
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Estimated Company Market Share Analysis, 2024
  • 9.5. List of Other Key Market Players